Polyvinylpyrrolidone Cross-linked (PVPP) Market – 2026 Outlook

MARKET INSIGHTS

Global Polyvinylpyrrolidone Cross-linked (PVPP) market size was valued at USD 167 million in 2024 and is projected to reach USD 254 million by 2032, growing at a CAGR of 6.3% during the forecast period.

Polyvinylpyrrolidone Cross-linked (PVPP) is an insoluble polymer known for its superior adsorption properties and chemical stability. Commonly referred to as insoluble PVP, this white powder plays a critical role as a disintegrant in pharmaceutical tablets, particularly instant-release and chewable formulations. Beyond pharma, PVPP serves as a high-performance clarifying agent in beer, wine, and beverage production, where it removes polyphenols to improve product clarity and shelf stability.

Market growth is driven by rising quality standards in food & beverage manufacturing and expanding pharmaceutical applications. The brewing industry accounted for 42% of global PVPP consumption in 2023, while pharmaceutical applications are growing at 7.1% CAGR due to increased tablet manufacturing. Recent regulatory approvals for PVPP in food contact applications across Europe and North America are further accelerating adoption. Key players like BASF and Ashland are investing in production capacity expansions to meet this demand, with three new manufacturing facilities announced in Asia-Pacific since 2023.

Polyvinylpyrrolidone Cross-linked (PVPP) Market – View in Detailed Research Report

Top 10 Companies in the Polyvinylpyrrolidone Cross-linked (PVPP) Market (2026)

1. 1. BASF SE

   Headquarters: Ludwigshafen, Germany
   Key Offering: Pharmaceutical-grade PVPP for tablet disintegrants and beverage clarifiers

   BASF SE is the market leader, leveraging its extensive chemical expertise and global distribution network. The company’s continuous R&D in polymer science and strategic acquisitions in excipient space have secured an 18% market share.

   Sustainability Initiatives:

   • Invested €120 million in green chemistry facilities
   • Reduced carbon footprint by 22% in PVPP production
   • Developed bio-based crosslinking methods cutting energy use by 25%

2. 2. Ashland Global Holdings

   Headquarters: Northbrook, Illinois, USA
   Key Offering: High-purity PVPP for pharmaceutical tablets and beer stabilization

   Ashland’s recent $120 million expansion of its German PVPP plant underpins its commitment to European demand, especially in beer stabilization where PVPP accounts for 40% of applications.

   Sustainability Initiatives:

   • Zero-waste production processes
   • Renewable energy sourcing for 70% of facilities
   • Regenerable PVPP systems for beverage use

3. 3. Sichuan Tianhua

   Headquarters: Chengdu, China
   Key Offering: Cost-competitive pharmaceutical-grade PVPP

   With government support under “Made in China 2025”, Sichuan Tianhua holds 25% of the Asia‑Pacific market share, supplying both domestic pharma and brewing sectors.

   Sustainability Initiatives:

   • Local sourcing of N‑vinylpyrrolidone monomers
   • Waste minimization program reducing by 30%
   • Energy-efficient production lines

4. 4. Jiangxi Alpha Hi‑tech Pharmaceutical

   Headquarters: Nanchang, China
   Key Offering: High‑purity PVPP for generic drug manufacturing

   The company’s focus on stringent pharmacopeial compliance positions it as a premium supplier in emerging markets.

   Sustainability Initiatives:

   • ISO 14001 certified facilities
   • Reduced water usage by 18%
   • Investment in renewable energy projects

5. 5. Anhui Sunhere Pharmaceutical Excipients

   Headquarters: Hefei, China
   Key Offering: Specialty PVPP grades for injectable and oral formulations

   Known for high-purity grades, Anhui Sunhere serves both domestic and international pharmaceutical clients.

   Sustainability Initiatives:

   • Biodegradable packaging
   • Carbon-neutral production goal by 2030
   • Partnerships with green suppliers

6. 6. Guangdong Yumay Chemical

   Headquarters: Guangzhou, China
   Key Offering: Food‑grade PVPP for juices and wine

   Yumay’s PVPP enhances clarity and shelf life for processed foods and beverages.

   Sustainability Initiatives:

   • Renewable energy usage of 60%
   • Water recycling program
   • Reduced plastic packaging

7. 7. JRS Pharma

   Headquarters: Stuttgart, Germany
   Key Offering: High‑purity PVPP for injectable drug formulations

   JRS Pharma’s expertise in meeting stringent pharmacopeial standards allows premium pricing in North America and Europe.

   Sustainability Initiatives:

   • Zero‑emission production lines
   • Closed‑loop water system
   • Green chemistry R&D

8. 8. ISP Pharmaceuticals

   Headquarters: Irvine, California, USA
   Key Offering: Pharmaceutical‑grade PVPP for generics and specialty tablets

   ISP’s focus on high‑purity grades and robust quality control drives demand in regulated markets.

   Sustainability Initiatives:

   • Carbon‑offset program
   • Energy efficiency upgrades
   • Supplier sustainability audits

9. 9. Boai NKY Pharmaceuticals

   Headquarters: Hangzhou, China
   Key Offering: Cost‑effective PVPP for domestic pharma

   Boai NKY’s production capacity expansion supports China’s growing generic drug market.

   Sustainability Initiatives:

   • Waste‑to‑energy conversion
   • Renewable electricity sourcing
   • Eco‑friendly packaging

10. 10. Huangshan Bonsun Pharmaceuticals

    Headquarters: Huangshan, China
    Key Offering: PVPP for oral and chewable tablets

    Huangshan’s focus on affordability and quality positions it as a key supplier in Asia‑Pacific.

    Sustainability Initiatives:

    • Green facility design
    • Reduced CO₂ emissions by 15%
    • Community sustainability programs

Download FREE Sample Report

Get Full Report Here

Outlook

While traditional PVPP applications remain strong, the market is shifting toward high‑purity specialty grades and sustainable production methods. Regulatory approvals in food and pharma sectors, coupled with rising consumer demand for clean‑label products, are expected to drive growth. Technological innovations such as ultra‑fine particle engineering will open new high‑margin opportunities in transdermal and wound‑care markets.

Future Trends

• Expansion of PVPP use in pediatric and geriatric tablet formulations.
• Growth of regenerable PVPP systems in beverage clarifying processes.
• Increased adoption of bio‑based crosslinking to reduce energy consumption.
• Emergence of alternative adsorbents may challenge PVPP dominance in cost‑sensitive segments.
• Greater emphasis on sustainability certifications across all regions.